back to US directory
us clinical guidance

Amyotrophic lateral sclerosis recognition and multidisciplinary care

US urgent recognition, specialist diagnosis, respiratory and nutrition surveillance, multidisciplinary care and preference-sensitive planning for ALS.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults with suspected or confirmed amyotrophic lateral sclerosis. The US term is ALS; motor neuron disease is broader. The AAN management guideline is older but reaffirmed in 2023 and supplemented by the 2022 quality-measure update. This page does not provide diagnostic criteria, gene-specific therapy eligibility or ventilator and feeding-tube protocols.
sources for this section:AAN ALS 2009/2023AAN ALS quality 2023

The Bottom Line

  • Suspect ALS with progressive focal weakness, wasting, fasciculation, spasticity or bulbar dysfunction that combines upper- and lower-motor-neuron features without sensory loss explaining the syndrome.
  • Refer promptly to neuromuscular expertise for confirmation and mimic exclusion; do not delay until multiple limbs are affected or respiratory symptoms become obvious.
  • Build and update a multidisciplinary plan spanning neurology, respiratory care, nutrition, speech and communication, rehabilitation, mental health, genetics, social work and palliative support.
  • Discuss available disease-modifying pharmacotherapy, clinical trials and supportive interventions through shared decisions, recognizing benefit, burden, function and the patient鈥檚 priorities.
sources for this section:AAN ALS 2009/2023AAN ALS quality 2023

Practical clinical workflow

1
Document region of onset, tempo, cramps, fasciculations, swallowing, speech, weight, breathing, orthopnea, cognition and behavior; examine bulbar, limb and respiratory motor function and search for mimics.
2
Arrange electrodiagnostic and targeted imaging or laboratory evaluation through specialist care and offer genetic counseling and testing according to current ALS recommendations and patient preference.
3
Screen respiratory function, dysphagia, weight and nutrition at regular intervals rather than waiting for crisis; introduce communication, mobility and secretion support early enough to be useful.
4
Review goals, advance care planning, ventilation and feeding preferences iteratively as disease changes, including hospice and caregiver support without equating palliative care with abandonment.
sources for this section:AAN ALS 2009/2023AAN ALS quality 2023

Safety boundaries and escalation

  • Dyspnea at rest, orthopnea, morning headache, weak cough, secretion retention, aspiration, inability to swallow or rapid weight loss requires urgent respiratory and nutrition assessment.
  • Acute deterioration can reflect pneumonia, pulmonary embolism, medication effect or another treatable emergency and should not be assumed to be inevitable ALS progression.
  • Avoid supplemental oxygen alone for neuromuscular hypoventilation without expert assessment because ventilation failure and carbon-dioxide retention may be missed.
  • Screen for depression, pseudobulbar affect, frontotemporal cognitive or behavioral change, suicidality and caregiver crisis because these alter communication, consent and safety planning.
sources for this section:AAN ALS 2009/2023AAN ALS quality 2023

Localization

US ALS care may involve an ALS Association certified center, VA ALS system, Medicare, Medicaid or commercial benefits; equipment and home-care coverage vary. The AAN sources are reaffirmed but older and remain behind specialist review.
sources for this section:AAN ALS 2009/2023AAN ALS quality 2023

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American Academy of NeurologyUpdate: The Care of the Patient with Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Management, and Cognitive/Behavioral Impairment2009 practice guideline; reaffirmed 2023-02-25; supplemented by the 2023 AAN ALS quality-measure set 路 published 2009-10-01 路 updated 2023-02-25 路 accessed 2026-08-20
    view source
  2. American Academy of Neurology Institute Quality Measure SubcommitteeAmyotrophic Lateral Sclerosis Quality Measurement Set 2022 UpdateDOI 10.1212/WNL.0000000000207386 路 published 2023-06-23 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.